• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,716.35(%)
  • Trent
    2,815.00 3,497.35(%)
  • Raymond
    1,024.00 1,024.00(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 530.65(%)
  • One 97
    1,829.50 1,829.50(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,727.35(%)
  • Britannia Inds.
    4,946.05 4,946.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vivanza Biosciences Ltd Trading

  • Indian Private
  • BSE Code : 4834.0
  • ISIN : INE984E01035
1.89 0 (0.53%)
  • As on 13 Sep 2026 (EOD)

  • Today’s Low

    1.88

  • Today’s High

    1.90

  • Open

    1.88

  • Perv Close

    1.88

  • 52W Low

    1.52

  • 52W High

    2.72

Key Indicators

  • P/E(TTM)

    14.54

  • Mar.Cap (₹Cr.)

    7.56

  • Div & Yield %

    0.00

  • Book Value(₹)

    1.10

  • Debt-Equity Ratio

    0.53

  • AGM Date

    11-Sep-2026

  • EPS

    0.13

  • P/E Ratio

    14.54

Financials Ratios

  • Debt-Equity Ratio

    1.51

  • Mar.Cap (₹Cr.)

    7.56

  • RONW (%)

    12.60

  • ROCE (%)

    10.23

Score Board

  • Equity (₹ in Cr.)

    4.00

  • BV (₹)

    1.10

  • Sales( ₹ in Cr.)

    112.23

  • NP (in Cr.)

    0.38

  • NP Var(%)

    154.0

  • Div%

    0.0

  • CPS (₹)

    0.10

  • EPS (₹)

    0.10

  • Traded Value (₹ in Lakhs)

    7.56

  • 52 Week High

    2.72

  • 52 Week Low

    1.52

  • Price BSE

    2.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    7.56

  • P/C Ratio

    20.20

  • P/E Ratio

    21.30

  • Price Vs.BV

    0.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 112.23 2.94 14.41 14.21 9.15 9.22
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 112.23 2.94 14.41 14.21 9.15 9.22
Other Income 0.11 0.03 0.05 0.39 0.83 0.50
Stock Adjustments 1.10 0.04 0.19 -0.62 1.83 -0.46
Total Income 113.44 3.01 14.65 13.98 11.81 9.26
EXPENDITURE :            
Raw Materials 112.07 2.67 13.17 12.34 10.31 8.11
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.33 0.37 0.31 0.22 0.08 0.11
Other Manufacturing Expenses 0.01 0.01 0.00 0.00 0.00 0.00
Selling and Administration Expenses 0.19 0.24 0.26 0.21 0.34 0.35
Miscellaneous Expenses 0.02 0.07 0.06 0.09 0.17 0.07
Employee Benefit Expenses 0.33 0.37 0.31 0.22 0.08 0.11
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 112.62 3.35 13.79 12.86 10.90 8.64
Operating Profit 0.82 -0.33 0.86 1.12 0.90 0.63
Interest 0.28 0.35 0.42 0.43 0.43 0.47
Gross Profit 0.54 -0.68 0.44 0.69 0.47 0.16
Depreciation 0.02 0.01 0.01 0.00 0.01 0.01
Profit Before Tax 0.52 -0.69 0.43 0.69 0.46 0.15
Current Tax 0.14 0.00 0.11 0.12 0.00 0.05
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 0.38 -0.70 0.32 0.57 0.46 0.10
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.38 -0.70 0.32 0.57 0.46 0.10
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.02 0.72 0.40 -0.17 -0.63 -0.73
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 0.40 0.02 0.72 0.40 -0.17 -0.63
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.09 -0.17 0.08 0.14 1.16 0.25
Earnings Per Share(Adj)-Unit Curr 0.09 -0.17 0.08 0.14 0.12 0.03
Book Value 1.10 1.01 1.18 1.10 9.57 8.41
Book Value(Adj)-Unit Curr 1.10 1.01 1.18 1.10 0.96 0.84

Shareholding Pattern

  • Promoter Group

    20.02%

  • Public Share Holding

    79.98%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,007,833 20.02 8,007,833 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,007,833 20.02 8,007,833 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 600 0.00 200 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 600 0.00 200 2
2] Non Institution
Bodies Corporate 1,600,094 4.00 1,596,544 20
Clearing Members 31,607 0.08 31,607 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 179,780 0.45 174,680 56
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 766,894 1.92 766,894 80
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,214,252 8.04 3,214,252 8
Individuals holding nominal share capital up to Rs. 1 lakh 26,180,428 65.45 24,667,188 19,077
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 8,000 0.02 8,000 2
Sub Total 31,991,567 79.98 30,469,677 19,250
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 40,000,000 100.00 38,477,710 19,254

Company Background

Vivanza Biosciences LtdTrading

  • Vivanza Biosciences Ltd
  • BSE Code : 4834.0
  • ISIN : INE984E01035

  • Incorporation Year

    1982

  • Registered Office

    403 Sarthik 2 Opp Rajpath Club
    S G Highway, Ahmedabad,
    Gujarat-380054

  • Telephone

    91-07405699869

  • FAX

  • Chairman

    Jayendra Mehta

  • Managing Director

    Jayendra Mehta

  • Company Secretary

    Vishal Katarmal

  • Auditor

    Shivam Soni & Co

  • Face Value

    1

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Vivanza Biosciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vivanza Biosci. 1.89 112.34 112.23 14.54 7.27
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77